|
|
Volumn 41, Issue 11, 2002, Pages 1380-1383
|
|
Genetics of Childhood Disorders: XLIV. Autism, Part 3: Psychopharmacology of Autism
a
a
b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUSPIRONE;
CARBAMAZEPINE;
CLOMIPRAMINE;
CLONIDINE;
DESIPRAMINE;
FENFLURAMINE;
FLUOXETINE;
FLUVOXAMINE;
GABAPENTIN;
GUANFACINE;
HALOPERIDOL;
LITHIUM;
METHYLPHENIDATE;
NALTREXONE;
NEUROLEPTIC AGENT;
NEUROPEPTIDE;
OPIATE ANTAGONIST;
OXYTOCIN;
PHENTERMINE;
PLACEBO;
PSYCHOSTIMULANT AGENT;
SEROTONIN;
SEROTONIN 1A AGONIST;
SEROTONIN AGONIST;
SEROTONIN UPTAKE INHIBITOR;
UNINDEXED DRUG;
VALPROIC ACID;
VASOPRESSIN;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
CENTRAL STIMULANT AGENT;
AGGRESSION;
AGITATION;
AGRANULOCYTOSIS;
AUTISM;
BEHAVIOR DISORDER;
CHILD BEHAVIOR;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CORRELATION ANALYSIS;
DEVELOPMENTAL DISORDER;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SAFETY;
DRUG TARGETING;
DRUG TOLERABILITY;
DRUG UTILIZATION;
EXTRAPYRAMIDAL SYMPTOM;
GRAND MAL EPILEPSY;
HUMAN;
HYPERACTIVITY;
HYPERSALIVATION;
HYPOTENSION;
INCREASED APPETITE;
IRRITABILITY;
MOOD DISORDER;
NAUSEA;
NONHUMAN;
OBSESSIVE COMPULSIVE DISORDER;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
PSYCHOSOCIAL WITHDRAWAL;
PULMONARY HYPERTENSION;
QT PROLONGATION;
REVIEW;
SEDATION;
SEIZURE;
SEROTONIN BLOOD LEVEL;
SIDE EFFECT;
SOCIAL INTERACTION;
STEREOTYPY;
SYMPTOM;
TACHYCARDIA;
TARDIVE DYSKINESIA;
TREMOR;
VALVULAR HEART DISEASE;
WEIGHT GAIN;
ARTICLE;
BLOOD;
GENETICS;
ADRENERGIC ALPHA-AGONISTS;
AUTISTIC DISORDER;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CLONIDINE;
HUMANS;
METHYLPHENIDATE;
SEROTONIN;
|
|
EID: 0036832316
PISSN: 08908567
EISSN: None
Source Type: Journal
DOI: 10.1097/00004583-200211000-00021 Document Type: Review |
|
Times cited : (23)
|
|
References (7)
|
